Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

Laura Bonapace(Friedrich Miescher Institute), Marie‐May Coissieux(Friedrich Miescher Institute), Jeffrey Wyckoff(Friedrich Miescher Institute), Kirsten D. Mertz(University Hospital of Zurich), Zsuzsanna Varga(University Hospital of Zurich), Tobias Junt(Novartis (Switzerland)), Mohamed Bentires‐Alj(Friedrich Miescher Institute)

Nature

October 21, 2014

10.1038/nature13862

Cited by 666

Abstract

Related Papers

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al.|Oncology|2013|13.2k

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network|Nature|2012|12.4k

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

Bin‐Zhi Qian, Jiufeng Li, Hui Zhang et al.|Nature|2011|2.8k

Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

Filip K. Świrski, Matthias Nahrendorf, Martin Etzrodt et al.|Science|2009|2.2k

Hallmarks of cancer: Interactions with the tumor stroma

Kristian Pietras, Arne Östman|Experimental Cell Research|2010|1.1k